Home > Insider Trading > Filing (0000921895-22-001177)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
907654	Arca Biopharma Inc.	ABIO	In Vitro & In Vivo Diagnostic Substances (2835)	363855489

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1752618	Funicular Fund, Lp	2261 Market Street #4307 San Francisco CA 94114		No	No	No	Yes
1922140	Jacob Ma-Weaver	2261 Market Street #4307 San Francisco CA 94114		No	No	No	Yes

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2022-04-04	122,342	$2.26	1,944,993	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Footnotes

This Form 4 is filed by the Funicular Fund LP (the "Fund") and Jacob Ma-Weaver (the "Reporting Persons"). The Reporting Persons and Cable Car Capital LLC ("Cable Car") may be deemed to be a member of a Section 13(d) group that may be deemed to collectively beneficially own more than 10% of the Issuer's outstanding shares of Common Stock. Each of the Reporting Persons and Cable Car disclaim beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein.
Represents a weighted average price. These Shares were purchased in multiple transactions at prices ranging from $2.1650 to $2.3050, inclusive of brokerage commissions. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Shares purchased at each separate price within the range set forth in this footnote.
Represents securities directly owned by the Fund. Cable Car, as the general partner of the Fund, may be deemed to beneficially own the securities directly owned by the Fund. Mr. Ma-Weaver, as the Managing Member of Cable Car, may be deemed to beneficially own the securities directly owned by the Fund.